Compare TECX & HOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TECX | HOV |
|---|---|---|
| Founded | 2019 | 1959 |
| Country | United States | United States |
| Employees | 60 | 1891 |
| Industry | | Homebuilding |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 554.1M | 595.5M |
| IPO Year | N/A | N/A |
| Metric | TECX | HOV |
|---|---|---|
| Price | $29.07 | $106.67 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 5 | 2 |
| Target Price | $75.20 | ★ $97.00 |
| AVG Volume (30 Days) | ★ 211.4K | 101.4K |
| Earning Date | 05-07-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $5.96 |
| P/E Ratio | ★ N/A | $17.50 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.39 | $85.69 |
| 52 Week High | $35.99 | $162.06 |
| Indicator | TECX | HOV |
|---|---|---|
| Relative Strength Index (RSI) | 52.26 | 49.90 |
| Support Level | $27.39 | $99.06 |
| Resistance Level | $31.17 | $113.60 |
| Average True Range (ATR) | 1.82 | 5.98 |
| MACD | 0.08 | 0.37 |
| Stochastic Oscillator | 66.98 | 59.51 |
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
Hovnanian Enterprises Inc conducts all of its homebuilding and financial services operations. The company designs, constructs, markets, and sells single-family detached homes, attached townhomes and condominiums, urban infill, and active lifestyle homes in planned residential developments. It has two distinct operations: homebuilding and financial services. Its homebuilding operations are divided geographically into three segments: Northeast, which includes Delaware, Maryland, New Jersey, Ohio, Pennsylvania, Virginia, and West Virginia; Southeast, which includes Florida, Georgia, and South Carolina; and West, which includes Arizona, California, and Texas. The firm generates maximum revenue from the West Segment.